Experimental Virology
Viruses are tiny vehicles that transport biological information to reprogram the functions of human, animal, or plant cells in order to replicate. So-called "enveloped" viruses consist of only one layer of proteins, are filled with genetic material, and are surrounded by a thin shell of lipids in which viral proteins are embedded. Even though viruses are tiny and have a simple build, viral pathogens such as the hepatitis C virus (HCV), respiratory syncytial virus (RSV), and SARS-CoV-2 have the potential to threaten the health of millions of people.
Here at the Institute for Experimental Virology, we focus on fundamental and translational RNA virus research. Our research groups combine the expertise of molecular and cell biological approaches with computational methods to help elucidate viral replication mechanisms to develop new therapeutic and preventive strategies.
Our research groups and their research foci:
- Pietschmann Lab – RG “Experimental Virology” – hepatitis C virus (HCV), hepatitis D Virus (HDV), Respiratory Sycytial Virus (RSV), Pandemic Preparedness (SARS-CoV2, Hantavirus a.m.m.)
- Behrendt Lab – RG „Translational Virology“– hepatitis E virus (HEV)
- Lauber Lab – RG “Computaional Virology” - genetic determinants for severe RSV infection; Identification and characterization of novel viruses and the human virome.
Prof. Dr. Thomas Pietschmann is a member of the RESIST cluster of excellence
In the video he explains his research focus in RESIST
This video was provided by the RESIST cluster of excellence.
Further information about Thomas Pietschmann in RESIST can be found here.
